Response by Kuwabara et al to Letter Regarding Article, “Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.